« Previous article
Latest Updates on CO...

22nd September 2020  Product update: various sources as indicated

Latest Updates on COVID-19 Testing - Kits, Products, Services, Instrumentation - 22 Sept 2020


This week's updates: Test wastewater for SARS-CoV-2 to establish COVID-19 prevalence in the community; simple test-card designed for on-the spot testing; strong positives show up in 3 minutes with test set for airports and a new CE-marked kit delivers quantitative measurement of antibodies for spike protein.

Plus, in next week's newsletter we are doing a special focus on kits for the upcoming winter flu + COVID-19 season. Discover what's available to allow your laboratory to run efficiently through these testing times.

New IDEXX RT-qPCR Test to Aid COVID-19 Wastewater-Based Epidemiology Efforts

New IDEXX RT-qPCR Test to Aid COVID-19 Wastewater-Based Epidemiology Efforts

Testing untreated wastewater can show prevalence of COVID-19 in communities and the new IDEXX Water SARS-CoV-2 RT-PCR test is a ready-to-use kit, validated in wastewater, that eliminates routine tasks and accelerates testing efforts. 
Find Out More

 

Rapid COVID-19 Antigen Test Card Suitable for On-the-Spot Testing 

Rapid COVID-19 Antigen Test Card Suitable for On-the-Spot Testing 

Lepu Medical's simple rapid antigen test card for the detection of SARS-CoV-2 has received CE-marking. The test provides a result in 15 minutes, takes swab specimens from the nasopharynx and oropharyngeal, and darkens in colour with an increase in viral load. 
Find Out More

 

Rapid 3-Minute COVID-19 Antigen Test Planned for Airports

Rapid 3-Minute COVID-19 Antigen Test Planned for Airports

QIAGEN has announced it will have its Access Anti-SARS-CoV-2 test available in US and EU markets once authorization is obtained. The test detects the nucleocapsid protein of the virus and can give result of a strong positive in 3 minutes. 
Find Out More

 

Quantiative Test Measures Antibodies for SARS-CoV-2 Spike Protein 

Quantiative Test Measures Antibodies for SARS-CoV-2 Spike Protein 

Roche has achieved CE-marking for its Anti-SARS-CoV-2 S antibody test that delivers a quantitative measurement of antibodies produced for the spike protein of the virus. The test can be used to evaluate the efficacy of vaccines and plasma donations. 
Find Out More


    

Tags:

Date Published: 22nd September 2020

Note: This content has been edited by a rapidmicrobiology staff writer for style and content.


View full company details




rapidmicrobiology.com

Address:

Cork

Ireland

Tel: +[353] 23 88 31884

Email Supplier

View full company details


Related news from rapidmicrobiology.com